GoHealth, Inc. (GOCO)

GoHealth’s Q1 2026 net revenues fell to $11.9M with a $66.1M net loss, heavy term-loan debt and tightening liquidity covenants leading management to disclose substantial doubt about its ability to continue as a going concern while DOJ False Claims Act litigation remains pending.

Gogoro (NASDAQ:GGR – Get Free Report) released its earnings results on Thursday. The company reported ($0.50) EPS for the quarter, FiscalAI reports. The company had revenue of $62.91 million for the quarter. Gogoro had a negative net margin of 28.71% and a negative return on equity of 53.91%. ...

Looking to buy Gogo Stock? Get the latest GOGO quote, news, earnings, forecast, price targets, and market insights. Start investing on Public.com.

Net revenues fell 94.6% year-over-year to $11.9 million, with a net loss of $66.1 million as the company scaled back Medicare Advantage activities and shifted focus to GoHealth Protect. Liquidity concerns raise substantial doubt about the ability to continue as a going concern.Original document: ...

To see the full list of analyst ... the GOCO Stock Forecast page. ... According to Spark, TipRanks’ AI Analyst, GOCO is a Neutral. The score is held down primarily by deteriorating financial performance (sharp revenue decline, large losses, and ongoing cash burn). Technicals add further pressure due…